Skip to Content

PD357 300 (Rezulin 300 mg)

Generic Name: troglitazone

Pill with imprint PD357 300 is White, Elliptical / Oval and has been identified as Rezulin 300 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.

Rezulin is used in the treatment of diabetes, type 2 and belongs to the drug class thiazolidinediones. There is no proven risk in humans during pregnancy. Rezulin 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PD357 300

Rezulin

Generic Name
troglitazone
Imprint
PD357 300
Strength
300 mg
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Thiazolidinediones
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC)
00071-0357

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.